Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster

Sep 11, 2022

New Delhi [India], September 11 : Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous...

Bharat Biotech applies for emergency use authorisation for its COVID-19 vaccine

Dec 07, 2020

New Delhi [India], December 7 : Bharat Biotech on Monday applied for emergency use authorisation for its indigenously developed COVID-19 vaccine 'Covaxin' to Drugs...

Serum Institute of India seeks emergency use authorisation for its COVID-19 vaccine 'Covishield'

Dec 07, 2020

New Delhi [India], December 7 : The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency...

SEC recommends regular market approval to Covaxin, Covishield for adults

Jan 19, 2022

New Delhi [India], January 19 : The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to...

Zydus Cadila seeks emergency authorisation for ZyCoV-D COVID-19 vaccine for 12 years, above

Jul 01, 2021

New Delhi [India], July 1 : Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller...

Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt sources

Jun 21, 2021

New Delhi [India], June 21 : The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin...